Mark Stevenson

Mark Stevenson is an experienced life sciences and diagnostics business leader with over 30 years’ experience commercializing innovations globally.

Mark served as Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific, a company with over $40B in sales and a world leader in serving science through, leading its life science solutions, analytical instruments, specialty diagnostics and laboratory products businesses. He joined Thermo Fisher as Executive Vice President and President of Life Sciences Solutions through the acquisition of Life Technologies. He has also previously served as President and Chief Operating Officer of Life Technologies, and President and Chief Operating Officer of Applied Biosystems prior to its merger with Invitrogen Corporation.

He currently serves on the board of Ingersoll Rand Inc. (NYSE: IR), The Binding Site and the Personalized Medicine Coalition.

Mark holds an M.B.A. from Henley Management School in the U.K., a degree in chemistry from Reading University, U.K.